G1 Therapeutics Inc Commercial update Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the G1 commercial update. (Operator Instructions) I would now like to turn the call over to your host, Will Roberts, you may begin.
Thank you, Kevin. Good morning, everyone, and welcome to the G1 conference call to discuss the expansion of our COSELA sales force and the mutual agreement with Boehringer Ingelheim to end our co-promotion agreement.
The press release was issued this morning and can be found in the news section of our corporate website www.g1therapeutics.com. And as Kevin mentioned, a Q&A session will follow the prepared comments.
Before we begin, I want to remind you today that today's webcast contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements represent management's judgment as of today and may involve risks and uncertainties that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |